EUVIMEDOpdag EUVIMED
Crossref

Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations

Karina W. Davidson, Ying Kuen Cheung, Thomas McGinn, Y. Claire Wang

NAM Perspectives · 2018-12-10

DOI: 10.31478/201812d ↗

At a glance

Journal article in NAM Perspectives, published online on 2018-12-10. Written by Karina W. Davidson and 3 co-authors. Cited 13 times so far (Crossref); 6 references. Funded by: National Institutes of Health.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Heterogeneous responses to the same therapy among individual patients are commonplace in both biomedical research and patient care. Despite being considered by many as the pinnacle of the evidence-based […]

Funding

  • National Institutes of Health

Cite

APA

Davidson, K. W., Cheung, Y. K., McGinn, T., & Wang, Y. C. (2018). Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations. NAM Perspectives. https://doi.org/10.31478/201812d

Vancouver

Davidson KW, Cheung YK, McGinn T, Wang YC. Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations. NAM Perspectives. 2018. doi:10.31478/201812d

BibTeX
@article{Davidson2018,
  author = {Davidson, Karina W. and Cheung, Ying Kuen and McGinn, Thomas and Wang, Y. Claire},
  title = {Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations},
  journal = {NAM Perspectives},
  year = {2018},
  doi = {10.31478/201812d}
}
Start for free →